Phase III study of selpercatinib vs chemotherapy +/ − pembrolizumab in untreated RET positive non-small-cell lung cancer
Future Oncology, Ahead of Print.
Source: Future Oncology - Category: Cancer & Oncology Authors: Benjamin J Solomon Cai Cun Zhou Alexander Drilon Keunchil Park J ürgen Wolf Yasir Elamin Hannah M Davis Victoria Soldatenkova Andreas Sashegyi Aimee Bence Lin Boris K Lin Herbert H F Loong Silvia Novello Edurne Arriola Maurice P érol Koichi Goto Fernand Source Type: research
More News: Cancer | Cancer & Oncology | Chemotherapy | Lung Cancer | Non-Small Cell Lung Cancer | Study